Kuhnil Pharm acquires approval of Omega-3/rosuvastatin combination drug for first time in the world

Kuhnil Pharm(CEO Young-Joong Kim) announced approval of Rosumega SC(generic name: omega-3-acids ethyl esters 90 + rosuvastatin) from the Ministry of Food and Drug Safety on the 31^st of July.

Rosumega SC will be used to treat combined dyslipidemia, which a level of LDL cholesterol is properly controlled, but a level of neutral fat is uncontrolled, for adult patients with a high-risk degree of c...